DrugCite
Search

MIGLITOL TABLET

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Miglitol Tablet Adverse Events Reported to the FDA Over Time

How are Miglitol Tablet adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Miglitol Tablet, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Miglitol Tablet is flagged as the suspect drug causing the adverse event.

Most Common Miglitol Tablet Adverse Events Reported to the FDA

What are the most common Miglitol Tablet adverse events reported to the FDA?

Hepatic Function Abnormal
62 (8.53%)
Alanine Aminotransferase Increased
48 (6.6%)
Aspartate Aminotransferase Increase...
48 (6.6%)
Liver Disorder
41 (5.64%)
Gamma-glutamyltransferase Increased
33 (4.54%)
Diarrhoea
18 (2.48%)
Blood Alkaline Phosphatase Increase...
17 (2.34%)
Ileus
17 (2.34%)
Nausea
17 (2.34%)
Anorexia
16 (2.2%)
Abdominal Distension
15 (2.06%)
Show More Show More
Hypoglycaemia
14 (1.93%)
Malaise
14 (1.93%)
Abdominal Pain
13 (1.79%)
Loss Of Consciousness
13 (1.79%)
Intestinal Obstruction
11 (1.51%)
Jaundice
11 (1.51%)
Large Intestine Carcinoma
10 (1.38%)
Vomiting
9 (1.24%)
Asthenia
8 (1.1%)
Hepatic Enzyme Increased
8 (1.1%)
Melaena
8 (1.1%)
Flatulence
7 (.96%)
Gastric Ulcer
7 (.96%)
Liver Function Test Abnormal
7 (.96%)
Anaemia
6 (.83%)
Diverticulum Intestinal Haemorrhagi...
6 (.83%)
Pruritus
6 (.83%)
Abdominal Pain Upper
5 (.69%)
Blood Creatinine Increased
5 (.69%)
Blood Lactate Dehydrogenase Increas...
5 (.69%)
Acidosis
4 (.55%)
Blood Glucose Increased
4 (.55%)
Epistaxis
4 (.55%)
Hyperkalaemia
4 (.55%)
Pneumonia
4 (.55%)
Pyrexia
4 (.55%)
Transaminases Increased
4 (.55%)
Acute Myocardial Infarction
3 (.41%)
Altered State Of Consciousness
3 (.41%)
Blood Bilirubin Increased
3 (.41%)
Cerebral Infarction
3 (.41%)
Chromaturia
3 (.41%)
Dehydration
3 (.41%)
Dyslalia
3 (.41%)
Electrolyte Imbalance
3 (.41%)
Erythema Multiforme
3 (.41%)
Gastrointestinal Haemorrhage
3 (.41%)
Hypoaesthesia Facial
3 (.41%)
Hypoproteinaemia
3 (.41%)
Ileus Paralytic
3 (.41%)
Iron Deficiency Anaemia
3 (.41%)
Multi-organ Failure
3 (.41%)
Nephrotic Syndrome
3 (.41%)
Oedema
3 (.41%)
Pallor
3 (.41%)
Pancreatitis Acute
3 (.41%)
Pneumatosis Intestinalis
3 (.41%)
Rhabdomyolysis
3 (.41%)
Small Intestinal Haemorrhage
3 (.41%)
Tremor
3 (.41%)
Anxiety
2 (.28%)
Atonic Seizures
2 (.28%)
Blood Creatine Phosphokinase Increa...
2 (.28%)
Blood Potassium Increased
2 (.28%)
Blood Pressure Diastolic Decreased
2 (.28%)
Blood Pressure Systolic Increased
2 (.28%)
Body Temperature Increased
2 (.28%)
Cholelithiasis
2 (.28%)
Constipation
2 (.28%)
Diverticulitis Intestinal Haemorrha...
2 (.28%)
Duodenal Ulcer
2 (.28%)
Extrasystoles
2 (.28%)
Faeces Discoloured
2 (.28%)
Fall
2 (.28%)
Femoral Neck Fracture
2 (.28%)
Haematuria
2 (.28%)
Heart Injury
2 (.28%)
Hemiplegia
2 (.28%)
Hepatic Neoplasm Malignant
2 (.28%)
Hypoaesthesia
2 (.28%)
Incontinence
2 (.28%)
Lacunar Infarction
2 (.28%)
Leukaemia
2 (.28%)
Myocardial Infarction
2 (.28%)
No Adverse Event
2 (.28%)
Pain
2 (.28%)
Peritonitis
2 (.28%)
Protein Total Decreased
2 (.28%)
Rash
2 (.28%)
Renal Impairment
2 (.28%)
Sudden Death
2 (.28%)
Abdominal Adhesions
1 (.14%)
Abortion Spontaneous
1 (.14%)
Adult T-cell Lymphoma/leukaemia
1 (.14%)
Atrial Septal Defect Acquired
1 (.14%)
Blood Glucose Decreased
1 (.14%)
Blood Pressure Systolic Decreased
1 (.14%)
Blood Triglycerides Increased
1 (.14%)
Cardiac Failure
1 (.14%)
Condition Aggravated
1 (.14%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Miglitol Tablet, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Miglitol Tablet is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Miglitol Tablet

What are the most common Miglitol Tablet adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Miglitol Tablet, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Miglitol Tablet is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Miglitol Tablet According to Those Reporting Adverse Events

Why are people taking Miglitol Tablet, according to those reporting adverse events to the FDA?

Diabetes Mellitus
140
Type 2 Diabetes Mellitus
36
Diabetes Mellitus Non-insulin-depen...
14
Post Gastric Surgery Syndrome
3
Hyperglycaemia
2
Ill-defined Disorder
1
Show More Show More

Miglitol Tablet Case Reports

What Miglitol Tablet safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Miglitol Tablet. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Miglitol Tablet.